Connect with us

Hi, what are you looking for?

News

Annovis Bio: End Of 2023 Parkinson’s Data Could Shift Momentum (NYSE:ANVS)

Annovis Bio (NYSE:ANVS) is a good speculative biotech play to look into. The reason why I state this is because it has a major catalyst expected by the end of this year. That is, at the

Read the full article here

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

News

Illumina, Inc. (NASDAQ:ILMN) Annual Evercore ISI HealthCONx Healthcare Conference December 3, 2024 9:00 AM ET Company Participants Ankur Dhingra – CFOSallilyn Schwartz – VP...

News

This article was written by Follow Long-only investment, evaluating companies from an operational, buy-and-hold perspective.Quipus Capital does not focus on market-driven dynamics and future...

News

America’s Car-Mart, Inc. (NASDAQ:CRMT) Q2 2025 Earnings Conference Call December 5, 2024 9:00 AM ET Company Participants Vickie Judy – CFODoug Campbell – President...

News

Genesco Inc. (NYSE:GCO) Q3 2025 Earnings Conference Call December 6, 2024 8:30 AM ET Company Participants Darryl MacQuarrie – Senior Director of FP&AMimi Vaughn...